文献速递脊柱外科骨质疏松与代谢性骨病创伤骨科

老年骨质疏松性椎体骨折患者的死亡率

Mortality among older adults with osteoporotic vertebral fracture.
PubMed 文献 · Osteoporos Int · 2023-05-26

该回顾性队列研究纳入2017至2019年美国医疗保险参保的骨质疏松性椎体骨折患者235,317例,比较接受与未接受椎体后凸成形术者的死亡风险。未匹配分析中椎体后凸成形术与死亡风险降低相关,但在按年龄和医疗并发症匹配后,接受椎体后凸成形术的患者死亡风险反而升高。

要点

  • 未匹配分析中椎体后凸成形术与死亡风险降低相关,调整后HR在组1为0.84(95%CI 0.82, 0.87),组2为0.88(95%CI 0.85, 0.91)。
  • 按医疗并发症和年龄+合并症匹配后,椎体后凸成形术与死亡风险升高相关,组3调整后HR为1.32(95%CI 1.25, 1.41),组4为1.81(95%CI 1.58, 2.09)。
  • 作者认为,严格倾向性匹配后椎体后凸成形术对死亡率的明显获益不再存在,说明在评估观察性数据时比较相似个体的重要性。

核心结论

  • 严格倾向性匹配后,椎体后凸成形术对椎体骨折患者死亡率的明显获益不再存在。

研究设计与样本

  • 回顾性队列研究,纳入2017至2019年美国医疗保险参保的骨质疏松性椎体骨折患者,比较接受与未接受椎体后凸成形术者。
  • 共分析235,317例患者,平均年龄81.1±8.3岁,女性占85.8%。
  • 预先设定2个对照组:组1为符合纳入标准的非骨水泥强化患者,组2为按人口学和临床变量倾向性匹配的患者;另设组3按医疗并发症匹配、组4按年龄+合并症匹配。

主要发现

  • 主要分析中,接受椎体后凸成形术者死亡风险降低:组1调整后HR为0.84(95%CI 0.82, 0.87),组2为0.88(95%CI 0.85, 0.91)。
  • 事后分析中,接受椎体后凸成形术者死亡风险升高:组3调整后HR为1.32(95%CI 1.25, 1.41),组4为1.81(95%CI 1.58, 2.09)。

关键数值与推荐

  • 组1调整后HR为0.84(95%CI 0.82, 0.87)。
  • 组2调整后HR为0.88(95%CI 0.85, 0.91)。
  • 组3调整后HR为1.32(95%CI 1.25, 1.41)。
  • 组4调整后HR为1.81(95%CI 1.58, 2.09)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We evaluated whether older adults who received kyphoplasty had reduced risk of mortality compared to those who did not. In unmatched analyses, those receiving kyphoplasty were at reduced risk of death but after matching on age and medical complications, patients who received kyphoplasty were at increased risk of death. PURPOSE: In previous observational studies, kyphoplasty for treatment of osteoporotic vertebral fractures has been associated with decreased mortality compared to conservative management. The purpose of this research was to determine whether older adults who received kyphoplasty had reduced risk of mortality compared to matched patients who did not. METHODS: Retrospective cohort study of US Medicare enrollees with osteoporotic vertebral fractures between 2017-2019 comparing patients who underwent kyphoplasty to those who did not. We identified 2 control groups a priori: 1) non-augmented patients who met inclusion criteria (group 1); 2) propensity-matched patients on demographic and clinical variables (group 2). We then identified additional control groups using matching for medical complications (group 3) and age + comorbidities (group 4). We calculated hazard ratios (HRs) and 95% confidence intervals (95% CIs) associated with mortality. RESULTS: A total of 235,317 patients (mean (± standard deviation) age 81.1 ± 8.3 years; 85.8% female) were analyzed. In the primary analyses, those who received kyphoplasty were at reduced risk of death compared to those who did not: adjusted HR (95% CI) in group 1 = 0.84 (0.82, 0.87); and in group 2 = 0.88 (0.85, 0.91). However, in post hoc analyses, patients who received kyphoplasty were at increased risk of death: adjusted HR (95% CI) in group 3 = 1.32 (1.25, 1.41) and 1.81 (1.58, 2.09) in group 4. CONCLUSION: An apparent benefit of kyphoplasty on mortality among patients with vertebral fractures was not present after rigorous propensity matching, illustrating the importance of comparing similar individuals when evaluating observational data.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Gold LS, Suri P, O'Reilly MK, et al. Mortality among older adults with osteoporotic vertebral fracture. Osteoporos Int. 2023. PMID: 37233794. doi:10.1007/s00198-023-06796-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。